Global Pharmaceuticals & Biotech Big Green Snowflakes

BioInfra

Market Cap: ₩26.0b

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials.

Fortrea Holdings

Market Cap: US$908.9m

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Moderna

Market Cap: US$9.5b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Brainstorm Cell Therapeutics

Market Cap: US$7.6m

A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

TRUBAR

Market Cap: CA$80.8m

Operates as a consumer products company with diversified assets in the plant-based and wellness consumer product categories in Canada.

Instituto Rosenbusch

Market Cap: AR$7.8b

Manufactures and sells veterinary products in Argentina.

Apimeds Pharmaceuticals US

Market Cap: US$25.4m

Operates as a clinical stage biopharmaceutical company in the United States.

Enanta Pharmaceuticals

Market Cap: US$178.1m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

CERo Therapeutics Holdings

Market Cap: US$6.0m

An immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.

HCW Biologics

Market Cap: US$6.1m

A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.

bioAffinity Technologies

Market Cap: US$7.2m

Engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.

Inventiva

Market Cap: €658.0m

A clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally.

Relief Therapeutics Holding

Market Cap: CHF 36.2m

A biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases.

Virpax Pharmaceuticals

Market Cap: US$13.8k

A preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments for central nervous system disorders.

iBio

Market Cap: US$17.3m

A preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases.

4Front Ventures

Market Cap: CA$4.6m

Engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States.

Grace Breeding

Market Cap: ₪86.1m

An agro-tech company, develops nitrogenous and climate change stress relief products in Europe, the United States, South America, and Israel.

Liminatus Pharma

Market Cap: US$63.7m

Operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies.

CanadaBis Capital

Market Cap: CA$6.2m

Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.

MindBio Therapeutics

Market Cap: CA$3.4m

Operates as a clinical stage drug development company in Australasia.

ImmuneOnco Biopharmaceuticals (Shanghai)

Market Cap: HK$5.4b

A biotechnology company, engages in the research and development of immuno-oncology therapies in the People’s Republic of China.

Cleo Diagnostics

Market Cap: AU$50.1m

A biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia.

Intech Biopharm

Market Cap: NT$2.9b

Engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally.

Hunan Er-Kang Pharmaceutical

Market Cap: CN¥7.8b

Manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally.

3D Medicines

Market Cap: HK$2.2b

A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the People’s Republic of China.

Kangmei Pharmaceutical

Market Cap: CN¥27.9b

Produces and sells Chinese herbal medicines in China.

ReproCELL

Market Cap: JP¥17.8b

Provides stem cell research and drug discovery services in Japan.

ChengDa Pharmaceuticals

Market Cap: CN¥4.2b

Engages in the research and development, production, and sale of pharmaceutical intermediates, chemical ingredients, and food and feed additives in China and internationally.

Silva Pharmaceuticals

Market Cap: ৳1.8b

Engages in manufacture and marketing of pharmaceutical products in Bangladesh and internationally.

SynCore BiotechnologyLtd

Market Cap: NT$924.8m

Engages in development and sale of food advisory, medicine inspection, and biotechnology service in Taiwan.

Godavari Drugs

Market Cap: ₹613.2m

Manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India.

Natural Capsules

Market Cap: ₹2.0b

Engages in manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally.

Hanshang Group

Market Cap: CN¥2.9b

Primarily engages in the retail business.

Ascendis Health

Market Cap: R506.9m

A health and wellness company, manufactures and distributes healthcare products in South Africa.

Prince Pharmaceutical

Market Cap: NT$975.5m

Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.

Pharma Equity Group

Market Cap: DKK 178.6m

Through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which current therapy is lacking or in need of improvement.